中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2011年
6期
51-52,54
,共3页
肝细胞癌%生长抑制DNA损伤诱导因子β%错配修复基因%hMLH1
肝細胞癌%生長抑製DNA損傷誘導因子β%錯配脩複基因%hMLH1
간세포암%생장억제DNA손상유도인자β%착배수복기인%hMLH1
Hepatocellular carcinoma%Gadd45β%Mismatch repair gene%hMLH1
目的 探讨Ga dd45β和hMLH1在肝细胞肝癌(HCC)中的表达及临床意义.方法 应用免疫组化方法检测Gadd45β和hMLH1在HCC和正常肝脏组织中的表达情况.结果 Gadd45β在HCC和正常肝组织中的阳性率分别为24%和90%;hMLH1在HCC和正常肝组织中的阳性率分别为42%和80%(P均<0.05);两者的表达成正相关(r=0.357,P<0.05),与HCC的肿瘤分化、门静脉癌栓及临床分期有关.结论 Gadd45β和hMLH1在肝癌均呈异常低表达,可能参与了肝癌的发生发展过程,在HCC的预防、诊断和治疗方面存在一定的临床意义.
目的 探討Ga dd45β和hMLH1在肝細胞肝癌(HCC)中的錶達及臨床意義.方法 應用免疫組化方法檢測Gadd45β和hMLH1在HCC和正常肝髒組織中的錶達情況.結果 Gadd45β在HCC和正常肝組織中的暘性率分彆為24%和90%;hMLH1在HCC和正常肝組織中的暘性率分彆為42%和80%(P均<0.05);兩者的錶達成正相關(r=0.357,P<0.05),與HCC的腫瘤分化、門靜脈癌栓及臨床分期有關.結論 Gadd45β和hMLH1在肝癌均呈異常低錶達,可能參與瞭肝癌的髮生髮展過程,在HCC的預防、診斷和治療方麵存在一定的臨床意義.
목적 탐토Ga dd45β화hMLH1재간세포간암(HCC)중적표체급림상의의.방법 응용면역조화방법검측Gadd45β화hMLH1재HCC화정상간장조직중적표체정황.결과 Gadd45β재HCC화정상간조직중적양성솔분별위24%화90%;hMLH1재HCC화정상간조직중적양성솔분별위42%화80%(P균<0.05);량자적표체성정상관(r=0.357,P<0.05),여HCC적종류분화、문정맥암전급림상분기유관.결론 Gadd45β화hMLH1재간암균정이상저표체,가능삼여료간암적발생발전과정,재HCC적예방、진단화치료방면존재일정적림상의의.
Objective To investigate the expression of Gadd45β and hMLH1 in hepatocellular carcinoma (HCC) and its clinical significance. Methods Expression of Gadd45β and hMLH1 was detected by immunohistochemical method in HCC and normal liver tissues. Results The positive rate of Gadd45β in HCC and normal liver tissues were 24% and 90% ;the positive rate of hMLH1 in HCC and normal liver tissues were 42% and 80%. The expression of Gadd45β and hMLH1 were positive correlated, their expression were related to tumor differentiation, tumor thrombus of portal vein and clinical stage. Conclusions The role of Gadd45β and hMLH1 in the development of HCC are exceptional inhibition. Gadd45β and hMLH1 maybe be involved in the development of HCC and have some clinical significance in HCC prevention, diagnosis and treatment.